6:27 PM
 | 
Jan 29, 2013
 |  BC Extra  |  Politics & Policy

CDER's Temple wants more CER trials for symptomatic treatments

Robert Temple, deputy center director for clinical science at FDA's Center for Drug Evaluation and Research, said he "would like to see more" comparative effectiveness trials for symptomatic treatments to help identify potential responders. In particular, Temple said trials that randomize...

Read the full 181 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >